Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clotrimazole + lactobacillus is a combination medication primarily used to treat vaginal infections, particularly vulvovaginal candidiasis (VVC). This combination leverages the antifungal properties of clotrimazole with the probiotic benefits of lactobacillus. Clotrimazole works by preventing the formation of the fungal protective covering, thereby stopping fungal growth. Lactobacillus acts as a probiotic that helps maintain vaginal health by producing anti-infectious substances and restoring the vaginal microecology. Clinical studies have shown that this combination may improve treatment outcomes for uncomplicated VVC compared to clotrimazole alone, with higher cure rates and better restoration of vaginal flora.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clotrimazole + lactobacillus.